Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07169877 · ClinicalTrials.gov registry record
Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?
A clinical trial of Hepatic Neoplasms, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 9,411
- Enrollment target
- 1
- Study location
NCT07169877: Completed study of Hepatic Neoplasms, sponsored by Icahn School of Medicine at Mount Sinai.
NCT07169877 is a study of Hepatic Neoplasms that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 9,411 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07169877, a study of Hepatic Neoplasms, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 9,411 participants
- Enrollment target
- 1
- Study location
Study Summary
A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmission, and reoperation.
Primary Outcome
Number of deaths at 30 days
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,411 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2023-12-31 |
What the finished NCT07169877 record still lists
NCT07169877 is an observational study that tracks outcomes without assigning an intervention. Its 9,411 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Hepatic Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT07169877 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07169877 about?
NCT07169877 is a clinical study titled "Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?". A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmissi...
What is the current status of trial NCT07169877?
This trial is currently completed. The enrollment target is 9,411 participants. The study started on 2022-01-01. Estimated completion is 2023-12-31.
What conditions does trial NCT07169877 study?
This clinical trial studies the following conditions: Hepatic Neoplasms.
Who is sponsoring clinical trial NCT07169877?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07169877 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
- NCT05080673 · 9,500 participants · NA
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI